Seres Therapeutics Inc (MCRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MCRB | AMGN | GILD | VRTX | BIIB |
| Company | Seres Therapeutics Inc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.7132 | 273.45 | 67.47 | 402.44 | 201.21 |
| High | 0.8290 | 274.35 | 67.90 | 403.88 | 205.36 |
| Low | 0.7002 | 267.24 | 65.09 | 393.00 | 198.11 |
| Last | 0.7427 | 269.38 | 65.27 | 397.70 | 202.46 |
| Change | +0.0132 | -3.63 | -1.81 | -3.06 | +0.47 |
| % Change | +1.81% | -1.33% | -2.70% | -0.76% | +0.23% |
| Volume | 3,441,100 | 1,794,000 | 15,171,900 | 787,600 | 1,590,300 |
| 20-Day Average Volume | 4,570,290 | 2,149,590 | 6,861,755 | 964,110 | 1,281,010 |
| Previous Close | 0.7295 | 273.01 | 67.08 | 400.76 | 201.99 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.6949 | 270.70 | 68.68 | 402.31 | 201.46 |
| 20-Day Raw Stochastic | 70.14% | 31.20% | 2.05% | 21.98% | 46.29% |
| 20-Day Relative Strength | 46.91% | 44.80% | 28.32% | 42.69% | 43.22% |
| Weighted Alpha | -88.72 | +9.12 | -23.73 | +14.87 | -34.48 |
| Today's Opinion | 88% Sell | 72% Sell | 100% Sell | 8% Buy | 88% Sell |
| Previous Opinion | 88% Sell | 40% Sell | 100% Sell | 8% Buy | 100% Sell |
| Last Month's Opinion | 100% Sell | 24% Buy | 88% Sell | 56% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +27.13% since 04/18/24 | +2.52% since 04/18/24 | -1.35% since 04/18/24 | +1.07% since 04/18/24 | +6.27% since 04/18/24 |
| Low | 0.5400 on 04/19/24 | 260.68 on 04/19/24 | 65.09 on 04/25/24 | 391.25 on 04/19/24 | 189.44 on 04/19/24 |
| High | 0.8290 on 04/25/24 | 274.86 on 04/24/24 | 67.90 on 04/25/24 | 406.86 on 04/23/24 | 205.75 on 04/24/24 |
| 1-Month | |||||
| %Chg | -5.68% since 03/25/24 | -4.07% since 03/25/24 | -10.07% since 03/25/24 | -4.41% since 03/25/24 | -6.57% since 03/25/24 |
| Low | 0.5400 on 04/19/24 | 260.68 on 04/19/24 | 65.09 on 04/25/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 0.8290 on 04/25/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 421.45 on 04/01/24 | 217.57 on 03/28/24 |
| 3-Month | |||||
| %Chg | -34.27% since 01/25/24 | -13.18% since 01/25/24 | -18.65% since 01/25/24 | -7.50% since 01/25/24 | -17.77% since 01/25/24 |
| Low | 0.5400 on 04/19/24 | 260.68 on 04/19/24 | 65.09 on 04/25/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 1.2600 on 01/29/24 | 329.72 on 02/05/24 | 80.51 on 01/26/24 | 448.40 on 01/30/24 | 251.99 on 01/31/24 |
| 6-Month | |||||
| %Chg | -45.99% since 10/25/23 | -1.02% since 10/25/23 | -16.74% since 10/25/23 | +9.55% since 10/25/23 | -17.94% since 10/25/23 |
| Low | 0.5400 on 04/19/24 | 249.70 on 10/31/23 | 65.09 on 04/25/24 | 341.90 on 11/16/23 | 189.44 on 04/19/24 |
| High | 2.0500 on 01/09/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 | 268.30 on 01/03/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 110,161 | 146,436,016 | 83,519,768 | 103,580,040 | 29,361,468 |
| Shares Outstanding, K | 151,009 | 536,376 | 1,245,077 | 258,459 | 145,361 |
| Annual Sales | 126,330,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 9,835,600,000 |
| Annual Net Income | -113,720,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 1,161,100,000 |
| Last Quarter Sales | 60,000 | 8,196,000,000 | 7,114,000,000 | 2,517,700,000 | 2,386,300,000 |
| Last Quarter Net Income | -41,250,000 | 767,000,000 | 1,429,000,000 | 968,800,000 | 249,700,000 |
| 60-Month Beta | 2.23 | 0.58 | 0.19 | 0.35 | -0.02 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.32 on 03/05/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 4.20 on 02/05/24 | 3.67 on 04/24/24 |
| Latest Earnings Date | 05/14/24 | 05/02/24 | 04/25/24 | 05/06/24 | 04/24/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.67 | 9.97 | 30.13 | 13.11 |